Advisory: MDS Nordion to Hold Analyst Conference Call to Discuss Signing of Framework Agreement with JSC Isotope
September 23 2010 - 5:00AM
PR Newswire (Canada)
OTTAWA, Sept. 23 /CNW/ -- OTTAWA, Sept. 23 /CNW/ - MDS Inc. (TSX:
MDS; NYSE: MDZ), a leading provider of products and services to the
global health science market, today announced it has entered into a
framework agreement with The Open Joint Stock Company "Isotope"
(Isotope), the authorized subsidiary of Rosatom State Corporation,
to explore and define areas of collaboration in the field of
supply, marketing and sale of isotopes produced in Russia.
Conference Call The Company will host an analyst conference call on
Monday, September 27, 2010 at 11:00 am ET with Steve West, Chief
Executive Officer to discuss the announcement. Peter Dans, Senior
Vice President and Chief Financial Officer and Jill Chitra, Senior
Vice President, Strategic Technologies & Regulatory Affairs
will accompany Mr. West on the call. You may dial 416-340-2216
(Toronto and international) or 1-866-226-1792 (toll free North
America) to join the call. Interested parties may also access the
live webcast of the conference call from the MDS Nordion website at
www.mdsnordion.com. Following the call, a telephone replay will be
available until Wednesday, October 27, 2010 by dialing 416-695-5800
or 1-800-408-3053, using access code: 6628440 followed by the
number sign. An audio archive will be available on the website at
http://www.mdsnordion.com/investors/webcasts_and_presentations.asp.
About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ) is a global health
science company that provides market-leading products and services
used for the prevention, diagnosis and treatment of disease. We are
a leading provider of innovative technologies for use in medical
imaging and radiotherapeutics, and sterilization technologies
benefiting the lives of millions of people in more than 65
countries around the world. Our products and services are used
daily by pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. MDS
has more than 600 highly skilled people in five locations. Find out
more at www.mdsnordion.com. MEDIA: Shelley Maclean, (613) 592-3400
x. 2414, shelley.maclean@mdsinc.com; INVESTORS: Ana Raman, (613)
595-4580, investor.relations@mdsinc.com
Copyright
Mds (NYSE:MDZ)
Historical Stock Chart
From May 2024 to Jun 2024
Mds (NYSE:MDZ)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Mds (New York Stock Exchange): 0 recent articles
More Mds News Articles